In addition, TLE5 inhibits the metastasis of colorectal cancer and prostate cancer by inhibiting the Notch and androgen receptor (AR) signaling pathways (Sonoshita et al., 2011; Okada et al., 2017; Wang et al., 2021a). Here, AR is linked to colorectal cancer.